FDA Approved: CLARINEX-D 12 HOUR — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental NDA for CLARINEX-D 12 HOUR, a desloratadine and pseudoephedrine sulfate combination, to expand its regulatory approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• CLARINEX-D 12 HOUR (DESLORATADINE AND PSEUDOEPHEDRINE SULFATE)

Snippet

SUPPL AP for CLARINEX-D 12 HOUR (DESLORATADINE AND PSEUDOEPHEDRINE SULFATE)